Dietary supplements containing botanical forms of caffeine and ephedra alkaloids have been widely promoted and used in the U.S. for weight loss and athletic enhancement despite a lack of adequate research on the pharmacology of these botanical stimulants. In order to analyze dietary supplements and perform human pharmacokinetic studies, an analytical approach with good precision and accuracy was needed with sufficient sensitivity to detect very low levels of ephedra alkaloids. A liquid chromatography-atmospheric pressure chemical ionization (APCI) tandem mass spectrometry (LC-MS-MS) method was developed for quantitating the various ephedrine-group alkaloids found in dietary supplements that contain Ephedra species, and in plasma and urine of persons consuming these supplements. Using this method, low nanogram-per-milliliter concentrations of ephedrine, pseudoephedrine, norephedrine, norpseudoephedrine, methylephedrine, methylpseudoephedrine, and caffeine can be quantitated in a 12-min LC-MS-MS run.
Introduction
Dietary supplements that contain botanical forms of ephedra alkaloids and caffeine were widely consumed in the United States for weight loss and athletic enhancement until growing concerns about the safety of these products (1-3) prompted the recent FDA ban on ephedra. Most of these supplements contain numerous phytochemicals intended to increase the product's thermogenic and ergogenic effects. However, published research investigating potential interactions between the individual active components is inadequate. Fundamental research into the pharmacology of these multi-component dietary supplements is urgently needed in order to understand the potential health risks posed by combinations of botanical stimulants.
To analyze the chemical composition of dietary supplement products and to carry out pharmacokinetic studies, a method for determination of the six ephedra alkaloids contained in Ephedra sp. (Figure 1 ) and the caffeine contained in guarana was required. A method that would have good precision and accuracy, and adequate sensitivity for determination of low nanogram-per-milliliter concentrations in plasma, and yet be convenient for analysis of large numbers of samples generated in clinical studies was desired. Previously reported methods for the determination of ephedra alkaloids have included highperformance liquid chromatography (HPLC) with ultraviolet (4) or fluorescence detection (5), gas chromatography (GC) (6), combined gas chromatography-mass spectrometry (GC-MS) (7), capillary electrophoresis (8) , and liquid chromatography-mass spectrometry (LC-MS) (9) . Numerous methods have been reported for analysis of herbal products, plant material and urine, but relatively few methods have been reported for quantitation of ephedra alkaloids in plasma. White et al. (10) reported a method using HPLC with ultraviolet detection for determination of ephedrine, pseudoephedrine, and methyle- phedrine in plasma following consumption of herbal products, but the sensitivity of the method was only adequate for pharmacokinetic characterization of the major alkaloid ephedrine. Methods for determination of ephedrine and norephedrine in plasma by HPLC after derivatization with 9-fluorenylmethyl chloroformate (5), and GC-MS determination of ephedrine and pseudoephedrine in plasma (7) have also been reported. However, none of the published methods that we are aware of are capable of simultaneously quantitating low nanogram-permilliliter concentrations of the six ephedra alkaloids in plasma. The purpose of this study was to develop and validate a new analytical method using liquid chromatography-tandem mass spectrometry (LC-MS-MS) with atmospheric pressure chemical ionization (APCI) for measuring the various ephedrinegroup alkaloids that are found in ma huang and apply this method to measure low levels in biological fluids of human research subjects.
Methods

Reagents and standards
(-)-Ephedrine hydrochloride and (+)-pseudoephedrine hydrochloride were obtained from the National Institute of Mental Health Chemical Synthesis Program, and provided to us courtesy of Dr. Paul Pentel of the University of Minnesota. These standards were cross-checked with ephedrine and pseudoephedrine standards obtained from Alltech-Applied Sciences (State College, PA) by preparing stock solutions from both sources and analyzing these stock solutions by LC-MS-MS as described. The analyzed concentrations from these two sources differed from each other by less than 5% of the mean. (1S,2R) Deuterium-labeled norephedrine/norpseudoephedrine and deuterium-labeled rnethylephedrine/pseudoephedrine were synthesized as described. 
Synthesis of internal standards
Benzaldehyde-2,3,4,5,6-ds. A solution of 2.08 mL (3.2 g, 20 mmol) bromobenzene-ds in 20 mL of anhydrous ether was stirred under an argon atmosphere while cooling with a dry ice/acetone bath. Butyilithium in hexanes [13.8 mL of 1.6M (22 mmol)] was added, and the solution was warmed to room temperature over ~ 15 rain. The slightly cloudy mixture was cooled again with a dry ice/acetone bath, and 2.7 mL (3 g, 22 retool) of N-methylformanilide was added, resulting in a creamy suspension. The reaction mixture was warmed to room temperature and stirred 15 rain, after which 50 mL of aqueous ~ 1M HCI was added. The organic layer was separated, and the aqueous layer was extracted with 50 mL of ether. The combined organic phases were washed successively with dilute sulfuric acid, aqueous sodium bicarbonate, and saturated aqueous NaC1, and then dried over anhydrous magnesium sulfate. The solvent was removed using a rotary evaporator, and the product was distilled bulb-to bulb (Kugelrohr) at ~ 100 mmHg, oven temperature 80-100~ to give 3.2 g of colorless liquid. GC-MS analysis indicated that the product was largely benzaldehyde-d5 (EI, m/z 111,100%, M § with some unreacted Nmethylformanilide as an impurity.
Norephedrine-ds/norpseudoephedrine-d5 mixture. Benzaldehyde-ds (1.4 g) nitroethane (2 g), and triethylamine (0.2 g) were mixed and stored in a freezer at ~ -20~ overnight. The reaction mixture, containing 1-(pentadeuterophenyl)-2-nitro-1-propanol, was cooled using an ice bath, and 20 mL of 50:50 (v/v) water/acetic acid were added. Zinc dust (10 g) was added portionwise with vigorous stirring. The reaction mixture was allowed to warm to room temperature and was stirred for 1 h. The solution was decanted from excess zinc, and the zinc was washed with 10 mL of water. The solution and aqueous wash was combined and made basic with 50% aqueous sodium hydroxide, enough base being added to dissolve the initial pre- Mean Conc. Percent of (ng/mL) (ng/mL) Expected cipitate of zinc salts. The solution was extracted with two 25-mL portions of methylene chloride, which were combined, and this was back-extracted with 25 mL of dilute aqueous sulfuric acid. The acid extract was made basic with sodium hydroxide, and then extracted with two 25-mL portions of methylene chloride. Solvent was removed from the combined extracts using a rotary evaporator to give 1.4 g of crude amine. The structure was confirmed by GC-MS (EI, m/z 44, 100%, CH3-CH=NH2 § and LC-MS (APCI, m/z 157, 100%, MH § m/z 139, 60%, MH § The hydrochloride salt was prepared from 0.7 g of the crude base by dissolving it in ~2 mL of isopropyl alcohol, and adding enough concentrated HCl to make the solution acidic. A few drops of the solution was evaporated to obtain seed crystals, which were added to the remaining solution along with 20 mL of anhydrous ether. The mixture was stirred, and then filtered to collect the product, which was washed with anhydrous ether and air dried to give 0.22 g of white powder.
Methylephedrine-dJmethylpseudoephedrine-ds mixture. A solution of 0.7 g of the described crude norephedrineds/norpseudoephedrine-d5 mixture in 10 mL of 10% aqueous acetic acid was cooled in an ice bath. Aqueous formaldehyde, 2 mL of 37%, was added, followed by 0.5 g of sodium Precision cyanoborohydride. The solution was stirred Coefficient overnight at room temperature, and then Because caffeine is present in nearly all human plasma samples, precision and accuracy at 10 ng/mL and 50 ng/mL was determined using an aqueous solution of 1% egg albumin, spiked with caffeine, to mimic plasma. At 500 ng/mL and at 3500 ng/mL human plasma was used. The mean values are "blank corrected", that is, concentrations were determined on samples (mean n = 6) that had not been spiked with caffeine, and these values were subtracted from the mean concentrations determined for the spiked samples.
Dietary supplement analysis
Thirty-five commercial dietary supplements were obtained from retail outlets and via the Internet for analysis of concentrations of ephedrine, pseudoephedrine, norephedrine, norpseudoephedrine, methylephedrine, methylpseudoephedrine, and caffeine. The enantiomeric purity of the alkaloids was assumed to be that reported previously for Ephedra species (11), but our analytical methods would not distinguish enantiomeric forms [e.g., (-)-ephedrine from (+)-ephedrine].
The material from three dose units (capsule, tablet, or liquid) was extracted by a method similar to that described by Gurley et al (4) .
The material from the capsules was ground using a mortar and pestle, weighed, and transferred to a 16 x 100-ram glass culture tube. To the tube was added 10 mL of 0.15M ammonium acetate buffer (pH 4) in 94:6 (v/v) water/methanol. The tube was heated at 80~ for 30 rain, cooled, and centrifuged. The supemate was diluted to 50 mL with the acetate buffer, and an aliquot was diluted 1:500 with HPLC-grade water and analyzed by LC-MS--MS as described for plasma and urine. Extraction recovery was tested by spiking material from three products with the seven alkaloids, and carrying the spiked material through the extraction procedure along with material that had not been spiked. The products tested were a tablet (Herbalife Thermojetics), a capsule (Ultra Ripped Thermogenic Pre-Workout Formula), and a powder (Ultimate Orange). Recoveries (accuracy) and precision are presented in Table I .
Method of analysis of biological fluid specimens
Plasma and urine specimens were stored frozen at -20~ Analyses of control specimens stored at -20~ indicated no significant loss in concentration over 16 months for plasma and 7 months for urine. To 0.5 mL of plasma sample, standard, or control contained in a 13 x 100-mm glass culture tube was added 100 pL of a solution of the internal standards in 0.01M HCI. The internal standard solution contained 1 pg/mL of ephedrine-d3, 1 pg/mL pseudoephedrine-d3, 1 pg/mL of a mixture of norephedrine-d5 and norpseudoephedrine-ds, and 1 pg/mL of a mixture of methylephedrine-d5 and methylpseudoephedrineds and 1 pg/ml of 13C3-caffeine. The tube was briefly vortex mixed, and 100 pL of 30% perchloric acid was added to precipitate the protein. After vortex mixing and centrifugation, the supemate was decanted to a new tube. 1~'ipotassium phosphate, 1 
The tube was vortex mixed for 5 rain, centrifuged, and placed in a dry ice-acetone mixture to freeze the aqueous layer. The organic layer was poured to a new tube, 100 pL of 10% HCl in methanol was added, and the extract was evaporated to dryness in a centrifugal vacuum evaporator. Urine samples were extracted using the same extraction procedure as for plasma, except that 100 pL of urine diluted to 0.5 mL with water was used. The dried extracts were reconstituted in 150 pL of 10raM ammonium formate/0.1% (v/v) formic acid in water, and transferred to an autosampler vial for LC-MS-MS analysis. The extraction recovery from plasma was 70-80% for the ephedra alkaloids and 55% for caffeine. Fifty-rnicroliter aliquots of the extracts were injected into the LC-MS-M8 system. A binary, linear gradient elution was used. The initial mobile phase composition was 100% A (10raM ammonium formate/0.1% formic acid in H20) changing to 80% A and 20% B (10raM ammonium formate/0.1% formic acid in methanol) over 7 rain, then to 100% B over 0.5 min; 100% B was maintained for 1 rain, after which the mobile phase was returned to 100% A for 3.5 rnin to equilibrate the column for the next injection. The run time was 12 rain per sample.
The MS was operated in the positive ion mode using atmospheric pressure chemical ionization (APCI). The vaporizer temperature was set at 500~ and the heated capillary was set at 200~ The sheath gas (nitrogen) was set at 80 psi and the auxiliary gas (also nitrogen) was set at 20 arbitrary units. Quantitative analyses were carried out using selected reaction monitoring (SRM), with the collision gas (argon) pressure in the second quadrupole set at -2.5 mTorr. The collision energy was set at 17 eV for the ephedra alkaloids and at 25 eV for caffeine. was used for urine. Because caffeine is con-1'5% sumed by the vast majority of the population, 2.6%
1.4% nearly all human plasma and urine samples 1.8% contain caffeine. Therefore, aqueous standards 1.8% were used to prepare calibration curves. Standard curves were linear from 0.5 ng/mL to 3600 103% ng/mL for caffeine in plasma. In urine, linearity was demonstrated up to 50 pg/mL for ephedrine and caffeine, up to 25 lag/mL for pseudoephedrine and norephedrine, up to 5 lag/mL for norpseudoephedrine, and up to 2.5 pg/mL for methylephedrine and methylpseudoephedrine. Eight concentrations spanning the range were used, and standards were run in duplicate. Typically, one set of standards was injected at the beginning of the run, and one set following injection of the clinical samples. Equations and correlation coefficients for representative standard curves are as follows: Precision and accuracy was evaluated by replicate analysis of spiked plasma samples and urine samples, at concentrations spanning the concentration ranges for the analytes in clinical study samples. (Tables II-IV ) This data supports a lower limit of quantitation (LLOQ) of 1 ng/mL for all ephedra alkaloids and 10 ng/mL for caffeine (12) . Because caffeine is present in nearly all human plasma samples, precision and accuracy at 10 ng/mL and 50 ng/mL was determined using an aqueous solution of 1% egg albumin, spiked with caffeine, to mimic plasma (Table II) . 
MS-MS analysis of caffeine isotopomers
To investigate the fragmentation pathway leading to the m/z 138 ion, we obtained MS--MS spectra (collision energy 25 eV) of four isotopomers of caffeine: 1,3-dirnethyl-7-(trideuteromethyl) xanthine; 1,7-dimethyl-3-(trideuteromethyl)xanthine; 3,7-dimethyl-1-(trideuteromethyl)xanthine; and 1,3-1SN2-2 - 
of Variation
ries, Andover, MA). The deuterium-labeled compounds were prepared in "test tube" reactions from the corresponding dimethylxanthines (theobromine, paraxanthine, and theophylline) and trideuteromethyl iodide by vortex mixing in dimethylformamide containing powdered potassium carbonate for a few minutes at room temperature. Aliquots of the reaction mixture were diluted and analyzed by LC-MS-MS (Figure 2 ).
Results and Discussion
It was anticipated that a method capable of quantitating low nanogram-per-miIIiliter concentrations would be required in order to adequately characterize the pharmacokinetics of the ephedra alkaloids following consumption of botanical products. Based on the chemical properties of the alkaloids and published methods, good sensitivity could be obtained using GC or GC-MS if the alkaloids are derivatized to improve chromatography. Several HPLC methods that are capable of separating the major ephedra alkaloids without the need for derivatization have been reported (4, 9, 13, 14) , but sensitivity might be marginal using a conventional ultraviolet detector. Because all of the analytes are basic compounds, it was expected that detection with high sensitivity could be obtained using MS with APCI or electrospray ionization (ESI), ionization modes that are commonly used in LC-MS. An LC-MS--MS method for quantitation of the six ephedra alkaloids and caffeine was developed because of the very high sensitivity and specificity attainable with tandem MS.
To facilitate processing large batches of samples, a simple liquid-liquid extraction procedure was developed, using a solvent mixture that remains liquid at-78~ allowing phase separations to be carried out by the freeze and pour technique. Because the ephedra alkaloids are three pairs of isomers (erythro/threo diastereomers, Figure 1 guished by mass, and HPLC separation was required. It has been reported that the six ephedra alkaloids can be separated using HPLC columns with a phenyl bonded phase, without using non-volatile ion pairing agents that would be undesirable for an LC-MS assay (9). Using a gradient elution with ammonium formate buffer, we found that the six alkaloids and caffeine can be separated with a 4.6-ram • 50-mm Hypersil Phenyl BDS column in a 12-rain run (Figure 3) .
With any MS assay, a stable isotope-labeled internal standard is desirable to correct for losses occurring during extraction and chromatography, thereby maximizing precision and accuracy. Deuterium-labeled analogues (side-chain trideuteromethyl) of ephedrine and pseudoephedrine, and carbon-13 labeled caffeine (trimethyl-]3C) were obtained commercially. In order to have stable isotope-labeled analogues of all analytes for internal standards, pentadeuterophenyl analogues of norephedrine and norspeudoephedrine, as a mixture, and pentadeuterophenyl analogues of methylephedrine and methylpseudoephedrine, also as a mixture, were synthesized. APCI was chosen as the ionization mode, since it is generally less sensitive than is ESI to suppression of ionization by co-extracted matrix components (15), and APCI was found to provide adequate sensitivity. MS-MS experiments revealed that for each of the Ephedra alkaloids, the protonated molecular ions (MH +) undergo collisioninduced dissociation (CID) predominately to the respective ions resulting from loss of water. Therefore, these ion transitions and the corresponding transitions for the internal standards were used for quantitation using selected reaction monitoring (SRM).
Caffeine to a neutral loss ofm/z 57, which can be explained by elimination of CHaNCO. We propose that this fragmentation occurs with elimination of the C-1 nitrogen atom and the C-2 carbon atom as shown in Figure 2 . Evidence to support this proposal was obtained from the MS-MS spectra of the three trideuteromethyl isotopomers. These spectra showed that the methyl group attached to the 1-nitrogen is lost in formation of the m/z 138 ion, whereas the other two are maintained. Further evidence for the proposed fragmentation pathway was obtained from the spectrum of 1,3-15N2-2-]3C-caffeine. CID of this isotopomer produced rn/z 139, consistent with the loss of N-1 and C-2.
Calibration curves were prepared from peak-area ratios using linear regression. They were linear from 0.5 to 1000 ng/mL for the ephedra alkaloids, and from 10 to 5000 ng/mL for caffeine in plasma. For urine, the linear range extended to 2.5-50 IJg/mL. Concentrations of the ephedra alkaloids as low as 1 ng/mL in plasma were readily measured. Precision and accuracy was evaluated by replicate analysis of spiked plasma and urine controls. Accuracy ranged from 97 to 118% of the expected concentration for the various analytes at concentrations spanning the expected ranges. Precision, as percent coefficient of variation, ranged from 0.1 to 4% (Tables I]-IV) . Chromatograms of a standard and of plasma extracts are shown in Figures 3-5. Data on precision and accuracy of the method applied to herbal products is presented in Table I Figure 5 . SRM chromatograms from an extract of plasma from a human subject following ingestion of an herbal product. Peak identification: NEPH, norephedrine; NPSE, norpseudoephedrine; EPH, ephedrine; PSE, pseudoephedrine; MEPH, methylephedrine; MPSE, methylpseudoephedrine; and CAF, caffeine. Concentrations were norephedrine, 6.9 ng/mL; norpseudoephedrine, 3.1 ng/mL; ephedrine, 21.8 n~mL; pseudoephedrine, 10.6 ng/mL; methytephedrine and methylpseudoephedrine, none detected, and caffeine, 728 ng/mL.
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Journal of Analytical Toxicology, Vol. 28, April 2004 The method used for the analyses, LC-MS-MS, is an extremely specific one, and the chance of interference would be expected to be small. Any interfering substance would have to have the same retention time and produce precursor and product ions with the same mass as the analyte. However, it occurred to us that the metabolites of methamphetamine and amphetamine, para-hydroxymethamphetamine and para-hydroxyamphetamine have the same molecular weights as ephedrine/pseudoephedrine and norephedrine/norpseudoephedrine, respectively, and they are substances that have a basic amino group. Therefore, they will produce the same precursor ions, m/z 166 and rn/z 152 as the analytes. Because of the relatively acidic phenolic hydroxy groups, however, these metabolites would not be expected to extract under the conditions of the assay, in which the samples are made strongly basic with tripotassium phosphate (pH ~ 14). These metabolites were tested for interference, and as expected, they were found not to interfere with the assay.
The specificity of the method was documented by analyzing blank matrix from several sources (12) . Plasma samples from 10 different individuals and urine samples from six individuals were analyzed. The urines samples were not obtained from the same individuals from which plasma was obtained. For all of the urine samples and 9 of the 10 plasma samples, no ephedra alkaloids were detected. One of the plasma samples contained 532 ng/mL pseudoephedrine, 35 ng/mL ephedrine, 37 ng/mL norpseudoephedrine, and 5 ng/mL norephedrine. We therefore suspected that this individual used a pharmaceutical product containing pseudoephedrine, and a pharmaceutical or herbal products containing ephedrine.
In summary, a sensitive LC-MS-MS method for quantitation of six ephedra alkaloids and caffeine in human biofluids and in herbal products has been developed. Precision and accuracy of the method is excellent. The extraction procedure is convenient for processing large batches of samples, and all seven analytes can be quantitated in a 12-min LC-MS-MS run.
